Vincerx Pharma, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Vincerx Pharma, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $17.70 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Fair Value Disclosures
us-gaap:LiabilitiesFairValueDisclosure · last filed 2021-11-12
- 2021-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $17.70M.
- 2021-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $11.10M.
- 2021-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $27.22M.
- 2020-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $32.31M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2021-09-30 | $17.70M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $11.10M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $27.22M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $32.31M 10-Q · filed 2021-11-12 |